Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Midgley

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|August 24, 1991
p53 immunostaining as a marker of malignant disease in diagnostic cytopathologyP A Hall, A Ray, N R Lemoine, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|January 30, 1995
On the regulation of the p53 tumour suppressor, and its role in the cellular response to DNA damageD P Lane, C A Midgley, T R Hupp, et al.
The EMBO Journal|November 24, 1999
SUMO-1 modification activates the transcriptional response of p53M S Rodriguez, J M Desterro, S Lain, et al.
Journal of Cell Science|May 1, 1995
Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivoC A Midgley, B Owens, C V Briscoe, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 1998
A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ miceA R Shoemaker, A R Moser, C A Midgley, et al.
The Journal of Biological Chemistry|November 29, 1996
Modification of two distinct COOH-terminal domains is required for murine p53 activation by bacterial Hsp70S Hansen, C A Midgley, D P Lane, et al.
Oncogene|January 19, 1995
Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the proteinB Vojtesek, H Dolezalova, L Lauerova, et al.
The Journal of Biological Chemistry|May 18, 1999
p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factorV Budhram-Mahadeo, P J Morris, M D Smith, et al.
Oncogene|May 24, 2000
An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivoC A Midgley, J M Desterro, M K Saville, et al.
International Journal of Cancer|September 9, 1991
p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasiaJ Bártková, J Bártek, J Lukás, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|August 24, 1991
p53 immunostaining as a marker of malignant disease in diagnostic cytopathologyP A Hall, A Ray, N R Lemoine, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|January 30, 1995
On the regulation of the p53 tumour suppressor, and its role in the cellular response to DNA damageD P Lane, C A Midgley, T R Hupp, et al.
The EMBO Journal|November 24, 1999
SUMO-1 modification activates the transcriptional response of p53M S Rodriguez, J M Desterro, S Lain, et al.
Journal of Cell Science|May 1, 1995
Coupling between gamma irradiation, p53 induction and the apoptotic response depends upon cell type in vivoC A Midgley, B Owens, C V Briscoe, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 1998
A resistant genetic background leading to incomplete penetrance of intestinal neoplasia and reduced loss of heterozygosity in ApcMin/+ miceA R Shoemaker, A R Moser, C A Midgley, et al.
The Journal of Biological Chemistry|November 29, 1996
Modification of two distinct COOH-terminal domains is required for murine p53 activation by bacterial Hsp70S Hansen, C A Midgley, D P Lane, et al.
Oncogene|January 19, 1995
Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the proteinB Vojtesek, H Dolezalova, L Lauerova, et al.
The Journal of Biological Chemistry|May 18, 1999
p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factorV Budhram-Mahadeo, P J Morris, M D Smith, et al.
Oncogene|May 24, 2000
An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivoC A Midgley, J M Desterro, M K Saville, et al.
International Journal of Cancer|September 9, 1991
p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasiaJ Bártková, J Bártek, J Lukás, et al.
Pageof 3